Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · DELAND, FL · NPI 1548748957
Verified facts
CMS Open Payments records show Christopher Lee Paik, MD received $177.50 in general payments during 2025 across 1 reported records.
Becton, Dickinson and Company accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $177.50 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $177.50 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| HemoSphere Normalized: hemosphere |
Device | Becton, Dickinson and Company | $177.50 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 698 | 176 |
| Atorvastatin Calcium | Atorvastatin Calcium | 582 | 169 |
| Amlodipine Besylate | Amlodipine Besylate | 434 | 136 |
| Losartan Potassium | Losartan Potassium | 418 | 132 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 417 | 136 |
| Lisinopril | Lisinopril | 354 | 104 |
| Gabapentin | Gabapentin | 309 | 75 |
| Metformin Hcl Er | Metformin Hcl | 302 | 81 |
| Pantoprazole Sodium | Pantoprazole Sodium | 262 | 83 |
| Simvastatin | Simvastatin | 227 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 217 | 62 |
| Metoprolol Succinate | Metoprolol Succinate | 213 | 67 |
| Valsartan | Valsartan | 184 | 54 |
| Metformin Hcl | Metformin Hcl | 180 | 52 |
| Alprazolam | Alprazolam | 179 | 51 |
| Omeprazole | Omeprazole | 174 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 155 | 53 |
| Tramadol Hcl | Tramadol Hcl | 147 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 146 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 129 | 32 |
| Allopurinol | Allopurinol | 121 | 39 |
| Furosemide | Furosemide | 117 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 36 |
| Sertraline Hcl | Sertraline Hcl | 106 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 104 | 19 |
| Eliquis | Apixaban | 103 | 27 |
| Atenolol | Atenolol | 102 | 26 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 102 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 99 | 27 |
| Diazepam | Diazepam | 98 | 27 |
| Potassium Chloride | Potassium Chloride | 94 | 27 |
| Lorazepam | Lorazepam | 86 | 39 |
| Trazodone Hcl | Trazodone Hcl | 86 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 82 | 28 |
| Enalapril Maleate | Enalapril Maleate | 79 | 25 |
| Jardiance | Empagliflozin | 79 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 78 | 23 |
| Memantine Hcl | Memantine Hcl | 78 | 23 |
| Nifedipine Er | Nifedipine | 76 | 18 |
| Ozempic | Semaglutide | 75 | 17 |
| Montelukast Sodium | Montelukast Sodium | 74 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 73 | 25 |
| Temazepam | Temazepam | 72 | 28 |
| Synthroid | Levothyroxine Sodium | 71 | 21 |
| Ezetimibe | Ezetimibe | 70 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | 22 |
| Clonazepam | Clonazepam | 68 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 66 | 18 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 63 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 18 |
| Pregabalin | Pregabalin | 61 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 59 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | 17 |
| Methylprednisolone | Methylprednisolone | 55 | 50 |
| Chlorthalidone | Chlorthalidone | 53 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 52 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 52 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 51 | 16 |
| Glipizide | Glipizide | 50 | 14 |
| Glipizide Er | Glipizide | 49 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 48 | suppressed |
| Carvedilol | Carvedilol | 47 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 46 | 12 |
| Meloxicam | Meloxicam | 46 | 14 |
| Finasteride | Finasteride | 45 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | 12 |
| Prednisone | Prednisone | 45 | 29 |
| Warfarin Sodium | Warfarin Sodium | 45 | 12 |
| Lovastatin | Lovastatin | 44 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 43 | 15 |
| Famotidine | Famotidine | 43 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 42 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 39 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 14 |
| Spironolactone | Spironolactone | 37 | 12 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 36 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 36 | 11 |
| Celecoxib | Celecoxib | 35 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 31 |
| Buspirone Hcl | Buspirone Hcl | 34 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 25 |
| Estradiol | Estradiol | 33 | 19 |
| Glimepiride | Glimepiride | 32 | 11 |
| Insulin Lispro | Insulin Lispro | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 24 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Cephalexin | Cephalexin | 22 | 17 |
| Donepezil Hcl | Donepezil Hcl | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 21 | suppressed |
| Xarelto | Rivaroxaban | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Lactulose | Lactulose | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 12 |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Verapamil Sr | Verapamil Hcl | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | 13 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $177.50 · 1 records | Becton, Dickinson and Company | HemoSphere | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error